KREBSIMPFSTOFFE UND IMPFVERFAHREN
European patent · EP2956544 · In force
Register entry
- Publication number
- EP2956544
- Application number
- EP14752122
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 14, 2014
- Published
- Dec 23, 2015
- Granted
- Nov 1, 2017
- Protection ends at the latest
- Feb 13, 2034
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 39/00 (2006.01)C12N 5/10 (2006.01)C12N 5/00 (2006.01)C12N 5/07 (2010.01)C12N 15/09 (2006.01)
- Priority
- US 201361764789 P 14.02.2013
- PCT application
- PCT/US2014/016610 14.02.2014
- PCT publication
- WO2014/127296 21.08.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 1, 2025
Change
Published in Swissreg on 01.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- May 2, 2019
Address changed
- Owner
- Immunocellular Therapeutics Ltd., 23622 Calabasas Road, Suite 300, Calabasas, CA 91302, USA → ImmunoCellular Therapeutics, Ltd., 30721 Russell Ranch Road, Suite 140, Westlake Village, CA 91362, USA
Published in Swissreg on 02.05.2019
- Nov 1, 2017
Granted
Published in Swissreg on 01.11.2017
Parties
Holder
Inventor
BENDER, James G.
Rancho Santa Margarita California 92688, US
YU, John S.
Los Angeles California 90049, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.